Rapid and quantitative phage susceptibility test by ramanome
mLife · 2026-06 · 5 (3) · 369-382
DOI: 10.1002/mlf2.70089 ↗Kurz gefasst
Fachartikel in der Zeitschrift mLife, online erschienen am 21.05.2026. Verfasst von Xiao Han und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering University of Jinan Jinan China. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Antimicrobial resistance poses an escalating global threat, renewing interest in bacteriophage therapy as a precision alternative to antibiotics. However, clinical translation remains hindered by the lack of rapid and quantitative phage susceptibility testing (PST) platforms capable of evaluating host range, infection potency, and effective multiplicity of infection (MOI). Here, we present a ramanome‐based phage susceptibility test (RPST), a phenotypic platform that captures infection‐induced remodeling of bacterial macromolecular composition to unify these diagnostic requirements within a single workflow. RPST integrates four Raman biomarkers into a Composite Infection Index (CII), enabling rapid and lysis‐independent discrimination between susceptible and resistant bacterial populations within ~1 h, with 96.0% categorical concordance (24/25) to plaque assays. As a continuous population‐level metric, CII quantifies the proportion of infected cells, allowing quantitative ranking of phage potency against shared hosts. By resolving CII trajectories across the MOI and time, RPST further determines the minimal effective MOI, which is the lowest phage‐to‐bacterium ratio sustaining self‐propagating infection, thereby defining the lower boundary for therapeutic feasibility. Together, these capabilities transform PST from static compatibility assays into a dynamic and quantitative framework that bridges in vitro infectivity assessment and infection dynamics relevant to phage therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering University of Jinan Jinan China.
- Single-Cell Center, Shandong Energy Institute, Qingdao New Energy Shandong Laboratory, Qingdao Institute of Bioenergy and Bioprocess Technology Chinese Academy of Sciences Qingdao China.
- National Clinical Research Center for Infectious Diseases, Shenzhen Clinical Medical Research Center for Tuberculosis, Shenzhen Third People's Hospital Southern University of Science and Technology Shenzhen China.
- Molecular Biology Research Center & Center for Medical Genetics, School of Life Sciences Central South University Changsha China.
- University of Chinese Academy of Sciences Beijing China.
- Single-Cell Biotechnology Ltd. Qingdao China.
ORCID-Profile: Jian Xu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Han, X., Wan, X., Zhou, Y., Fu, X., Zheng, X., Gao, B., Huang, S., Ge, A., Huang, J., Lu, H., & Xu, J. (2026). Rapid and quantitative phage susceptibility test by ramanome. mLife, 5(3), 369-382. https://doi.org/10.1002/mlf2.70089
Vancouver
Han X, Wan X, Zhou Y, Fu X, Zheng X, Gao B, et al. Rapid and quantitative phage susceptibility test by ramanome. mLife. 2026;5(3):369-382. doi:10.1002/mlf2.70089
BibTeX
@article{Han2026,
author = {Han, Xiao and Wan, Xiaofu and Zhou, Yang and Fu, Xiaoting and Zheng, Xiaoshan and Gao, Bo and Huang, Shi and Ge, Anle and Huang, Jiadong and Lu, Hongzhou and Xu, Jian},
title = {Rapid and quantitative phage susceptibility test by ramanome},
journal = {mLife},
year = {2026},
volume = {5},
number = {3},
pages = {369--382},
doi = {10.1002/mlf2.70089}
}
EUVIMED